期刊文献+

Toll样受体4及Tollip蛋白在大肠癌中的表达及临床意义 被引量:3

Expression of Toll like receptor 4 and Tollip protein in colorectal carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨Toll样受体4(TLR4)及Tollip蛋白在大肠癌发生、发展过程中的作用。方法采用免疫组化SP法检测TLR4和Tollip蛋白在51例大肠癌癌组织和20例癌旁正常组织中的表达,并分析两者与大肠癌临床分期、病理分级的相关性。结果TLR4及Tollip蛋白在大肠癌组织中的表达显著强于癌旁正常组织,且两者表达随肿瘤临床病理分期进展及病理分级降低而升高(P<0.01)。结论TLR4、Tollip蛋白在大肠癌发生、发展过程中发挥一定免疫作用,可作为判断大肠癌进展程度的参考指标。 Objective To investigate the function of Toll like receptor 4 (TLR4)and Tollip protein in the pathogenesis and development of eolorectal carcinoma. Methods The expression of TLR4 and Tollip protein in 51 specimens of colorectal earcinoma and 20 specimens para-tumor tissue were determined by SP immtmohistochemistry method. The relation of the expression of TLR4 and Tollip protein and clinical stages , pathological grades were analyzed. Results The expression of TLR4 and Tollip protein were significantly higher in colorcctal carcinoma tissue than those in para-tumor tissue, and whieh increased with the decrease of clinical stages and pathological grades ( P 〈 0.01 ). Conclusions The expression of the TLR4 and Tollip protein play immunization in the pathogenesis and development of coloreetal carcinoma,can be used as reference index to estimate the development of colorcctal carcinoma.
出处 《山东医药》 CAS 北大核心 2009年第35期4-6,共3页 Shandong Medical Journal
基金 滨州医学院创新团队基金资助项目(BY51067)
关键词 TOLL样受体4 Tollip蛋白 肠肿瘤 大肠癌 Toll like receptor 4 Tollip protein colorectal tumor, colorectal carcinoma
  • 相关文献

参考文献10

  • 1Christione M, Friedenreich CM, Marie R, et al. Orenstein Physical Activity and Cancer Prevention: Etiologic Evidence and Biological Mechanisms [ J ]. Nutr, 2002,132 ( 11 ) : 3456 -3464.
  • 2Akira S, Takeda K, Kaisho T. Toll-like receptors: critical Proteins linking innate and acquired immunity [ J]. Nat Immunol, 2001,2 (8) :675-680.
  • 3Schjetue KW, Thompson KM, Nilsen N, et al. Cutting Edge: Link between innate and adaptive immunity: Toll-like receptor2 intemalizes antigen for presentation to CD4^+ T cells and could be an efficient vaccine target[ J]. J Immunol,2003,171 ( 1 ) :32-36.
  • 4Kirschning C J, Bauer S. Toll-like receptors : cellular signal transducers for exogenous molecular patterns causing immune responses [ J ]. Int J Med Micrebiol,2001,291 (4) :251-260.
  • 5Zhang G, Ghosh S. Negative regulation of Toll-like receptor-mediated signaling by Tollip[ J]. J Biol Chem,2002,277(9) :7059-7065.
  • 6Bendelae A, Mdezhitov R. Adjuvants of immunity : harnessing innate immnuity to promote adaptive immunity[ J]. J Exp Meal,2002,195 (5) : F19-F23.
  • 7Wang RF, Peng G, Wang HY. Regulatory T cells and Toll-like receptors in tumor immunity[ J]. Semin Immunol,2006, 18 (2) : 136- 142.
  • 8Molteni M, Mambella D, Orlandi C, et al. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4[ J]. Cancer Lett,2006,235 ( 1 ) :75-83.
  • 9Kelly MG, Alvero AB, Chen R. TLR-4 signaling promotes tumor growth and paelitaxel chemoresistance in ovarian cancer[ J]. Cancer Res,2006,66 (7) :3859-3868.
  • 10Bohnhorst J, Rasmussen T, Moen SH. Toll-like receptors mediate proliferation and survival of multiple myeloma cells [ J ]. Leukemia, 2006,20(6) :1138-1144.

同被引文献35

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部